Summit Completes Dosing of Ezutromid in PhaseOut DMD Clinical Trial
Go back to Summit Completes Dosing of Ezutromid in PhaseOut DMD Clinical Trial| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 12.82 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.82 | 52 Week High | $19.75 | |||
| Open | $12.82 | 52 Week Low | $4.26 | |||
| Day High | $12.82 | P/E | N/A | |||
| Day Low | $12.82 | EPS | $0.00 | |||
| Volume | 10,181 | |||||
| AyreTrade, Inc. (AMEX: SUMM) | Delayed: 0.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.06 | 52 Week High | $0.24 | |||
| Open | $40.78 | 52 Week Low | $0.02 | |||
| Day High | $0.06 | P/E | N/A | |||
| Day Low | $0.06 | EPS | $0.00 | |||
| Volume | 7,226,927 | |||||
